Hypertriglyceridemia and plasma insulin in combined familial hyperlipidemia

被引:0
|
作者
Ascaso, JF [1 ]
Sales, J [1 ]
Merchante, A [1 ]
Real, JT [1 ]
Lorente, RI [1 ]
MartinezValls, J [1 ]
Carmena, R [1 ]
机构
[1] UNIV VALENCIA, HOSP CLIN, SERV ENDOCRINOL & NUTR, E-46003 VALENCIA, SPAIN
来源
REVISTA CLINICA ESPANOLA | 1997年 / 197卷 / 11期
关键词
combined familial hyperlipidemia; hyperinsulinism; lipids and insulin; plasma triglycerides; insulin;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Changes in insulin secretion were investigated in a group of non obese subjects with combined familial hyperlipidemia (CFH), with normal glucose tolerance, relating the observed changes with plasma triglycerides and lipoprotein phenotype. Materials and methods. The study was conducted with 21 subjects (16 males and 5 females; mean age: 45.9 +/- 9.1 years), diagnosed of CFH after the clinical and analytical study of patients and their first degree relatives (9 with phenotype IIa, 8 IIb, and 4 IV) and 21 healthy control subjects, of similar age, sex and body weight. In both groups, lipids, plasma lipoproteins, glucose, basal plasma insulin, and insulin after and oral glucose overload (OGO) were quantitated. Results. Diastolic blood pressure was higher (p < 0.01) in CFH group compared with controls (means: 132/80 vs 123/71 mmHg, respectively). TC, TG and Apo B were also higher in the CFH group. With OGO significantly higher serum insulin levels were observed at 0, 30, 60, 90 and 120 minutes in CFH subjects compared with control group. Basal serum insulin and the area under the curve of insulin secretion after OGO was higher in subjects with triglycerides (45,579 +/- 13,056 in controls, 61,385 +/- 22,254 in CFM IIa, 70,645 +/- 17,271 IIb and 124,884 +/- 36,944 in CFH IV. Insulin secretion correlated significantly (p < 0.01) with plasma triglycerides. As conclusion, hyperinsulinism is a finding in CFH non obese subjects and with normal glucose tolerance, and has an increasing frequency in subjects with high triglycerides levels.
引用
收藏
页码:735 / 739
页数:5
相关论文
共 50 条
  • [31] Plasma PAI-1 levels are independently related to fatty liver and hypertriglyceridemia in familial combined hyperlipidemia, involvement of apolipoprotein E
    Brouwers, Martijn C. G. J.
    Govers-Riemslag, Jose
    Schalkwijk, Casper G.
    van Greevenbroek, Marleen M. J.
    van der Kallen, Carla J. H.
    Bekers, Otto
    van Dieijen-Visser, Marja P.
    ten Oever, Jaap
    Bilderbeek-Beckers, Monique A. L.
    de Bruin, Tjerk W. A.
    ten Cate, Hugo
    Stehouwer, Coen D. A.
    THROMBOSIS RESEARCH, 2008, 122 (04) : 466 - 472
  • [32] Lipoprotein lipase variant N291S is associated with hypertriglyceridemia in familial combined hyperlipidemia
    Lopez-Ruiz, A
    Martinez-Triguero, M
    Casado, M
    Jarabo, M
    Diaz-Ruiz, M
    Lopez-Gutierrez, A
    Casañ, R
    Morillas, C
    Hernandez-Mijares, A
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 11 - 11
  • [33] The hormone sensitive lipase gene in familial combined hyperlipidemia and insulin resistance
    Pihlajamäki, J
    Valve, R
    Karjalainen, L
    Karhapää, P
    Vauhkonen, I
    Laakso, M
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2001, 31 (04) : 302 - 308
  • [34] IMPAIRED GLUCOSE METABOLISM AND INSULIN RESISTANCE IN PATIENTS WITH FAMILIAL COMBINED HYPERLIPIDEMIA
    Lima, J.
    Moline, A.
    Fernandez, P.
    Sanz, X.
    Fonollosa, V.
    Vilardell, M.
    ATHEROSCLEROSIS, 2014, 235 (02) : E184 - E185
  • [35] Effects of rosuvastatin on insulin sensitivity in patients with familial combined hyperlipidemia (FCH)
    ter Avest, E
    Abbink, EJ
    de Graaf, J
    Tack, CJ
    Stalenhoef, AFH
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 123 - 123
  • [36] Twenty-year cardiovascular disease (CVD) mortality in familial combined hyperlipidemia and familial hypertriglyceridemia: An historical cohort study
    Austin, MA
    McKnight, B
    Edwards, KL
    Wallace, KJ
    Bradley, CM
    McNeely, MJ
    Brunzell, JD
    Motulsky, AG
    CIRCULATION, 1997, 96 (08) : 2304 - 2304
  • [37] Insulin resistance in patients with familial combined hyperlipidemia and coronary artery disease
    Ascaso, JF
    Lorente, R
    Merchante, A
    Real, JT
    Priego, A
    Carmena, R
    AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (11): : 1484 - 1487
  • [38] Combined hyperlipidemia is genetically similar to isolated hypertriglyceridemia
    Gill, Praneet K.
    Dron, Jacqueline S.
    Berberich, Amanda J.
    Wang, Jian
    McIntyre, Adam D.
    Cao, Henian
    Hegele, Robert A.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2021, 15 (01) : 79 - 87
  • [39] FAMILIAL COMBINED HYPERLIPIDEMIA WORKSHOP
    GRUNDY, SM
    CHAIT, A
    BRUNZELL, JD
    ARTERIOSCLEROSIS, 1987, 7 (02): : 203 - 207
  • [40] Genetics of familial combined hyperlipidemia
    Pajukanta P.
    Porkka K.V.K.
    Current Atherosclerosis Reports, 1999, 1 (1) : 79 - 86